Discovery of prognostic and treatment predictive biomarkers in recently diagnosed type 1 diabetes patients treated with anti TNFα

S Kostense, Jaco M Klap, H Ashoor, R Yang, GJ Weverling, K Sweet, MR Rigby, JA Hedrick
doi: https://doi.org/10.1101/2023.05.29.23290668

Article Information

doi 
https://doi.org/10.1101/2023.05.29.23290668
History 
  • June 5, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. S Kostense, PhD1,*,
  2. Jaco M Klap, MSc1,
  3. H Ashoor, PhD2,
  4. R Yang, PhD2,
  5. GJ Weverling, MD PhD1,
  6. K Sweet, PhD3,
  7. MR Rigby, MD PhD3 and
  8. JA Hedrick, PhD3
  1. 1Janssen R&D, Leiden, The Netherlands
  2. 2Janssen R&D, Boston, MA, USA
  3. 3Janssen R&D, Horsham, PA, USA
  1. ↵*Corresponding author: S Kostense: Stefan.kostense{at}crl.com
Back to top
Posted June 05, 2023.
Download PDF
Data/Code
Email
Discovery of prognostic and treatment predictive biomarkers in recently diagnosed type 1 diabetes patients treated with anti TNFα
S Kostense, Jaco M Klap, H Ashoor, R Yang, GJ Weverling, K Sweet, MR Rigby, JA Hedrick
medRxiv 2023.05.29.23290668; doi: https://doi.org/10.1101/2023.05.29.23290668
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area